Peter Smaldone is a seasoned commercial leader in the biopharmaceutical industry, currently serving as the Commercial Business Director for the US BioPharmaceuticals Business Unit and the Cardiovascular Metabolics Division at AstraZeneca since September 2015. Prior to this role, Peter held various positions at Eli Lilly and Company from 2006 to August 2015, including Executive Account Manager and District Sales Manager. Peter's educational background includes a Bachelor of Science in Marketing from Post University, completed in 2006.
This person is not in any teams
This person is not in any offices